These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38132029)

  • 1. Patients' Expectations and Satisfaction with the Patient-Doctor Relationship in Hidradenitis Suppurativa.
    Rymaszewska JE; Karczewski M; Krajewski PK; Matusiak Ł; Maj J; Szepietowski JC
    Healthcare (Basel); 2023 Dec; 11(24):. PubMed ID: 38132029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Satisfaction with Life and Coping Strategies among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study.
    Rymaszewska JE; Krajewski PK; Matusiak Ł; Maj J; Szepietowski JC
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
    Krajewski PK; Marrón SE; Tomas Aragones L; Gilaberte-Calzada Y; Szepietowski JC
    Dermatol Ther (Heidelb); 2022 Apr; 12(4):899-909. PubMed ID: 35274220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression and anxiety in hidradenitis suppurativa patients: a cross-sectional study among Polish patients.
    Rymaszewska JE; Krajewski PK; Szczęch J; Szepietowski JC
    Postepy Dermatol Alergol; 2023 Feb; 40(1):35-39. PubMed ID: 36909902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview and comparison of the clinical scores in hidradenitis suppurativa: A real-life clinical data.
    Daoud M; Suppa M; Benhadou F; Daxhelet M; Njimi H; White J; Jemec G; Del Marmol V
    Front Med (Lausanne); 2023; 10():1145152. PubMed ID: 37138732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
    Włodarek K; Stefaniak A; Matusiak Ł; Szepietowski JC
    Dermatology; 2020; 236(1):8-14. PubMed ID: 31487719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
    Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
    Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated with Severe Hidradenitis Suppurativa, Using Hurley Staging and Metascore.
    Daoud M; Suppa M; Benhadou F; Heudens S; Sarkis AS; Njimi H; Saunte SK; Desmarest L; Orte Cano C; Dandoy C; Nobile L; Fontaine M; Daxhelet M; Karama J; White JM; Jemec GBE; Del Marmol V
    Dermatology; 2024 Oct; ():1-19. PubMed ID: 39396514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with Hidradenitis Suppurativa Suffer from Low Health-Related Quality of Life as Measured by the Generic 15D Instrument.
    Hirvonen MJ; Pasternack R; Lipitsä T; Vihervaara A; Harvima R; Ranta M; Sintonen H; Huilaja L
    Skin Appendage Disord; 2022 May; 8(3):221-227. PubMed ID: 35702276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
    Zouboulis CC; Tzellos T; Kyrgidis A; Jemec GBE; Bechara FG; Giamarellos-Bourboulis EJ; Ingram JR; Kanni T; Karagiannidis I; Martorell A; Matusiak Ł; Pinter A; Prens EP; Presser D; Schneider-Burrus S; von Stebut E; Szepietowski JC; van der Zee HH; Wilden SM; Sabat R;
    Br J Dermatol; 2017 Nov; 177(5):1401-1409. PubMed ID: 28636793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The psychosocial burden of hidradenitis suppurativa in Singapore.
    Ooi XT; Choi E; Han H; Ahmad H; Patwardhan KR; Chandran NS
    JAAD Int; 2023 Mar; 10():89-94. PubMed ID: 36691658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.
    Montero-Vilchez T; Diaz-Calvillo P; Rodriguez-Pozo JA; Cuenca-Barrales C; Martinez-Lopez A; Arias-Santiago S; Molina-Leyva A
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab Dose Intensification in Recalcitrant Hidradenitis Suppurativa/Acne Inversa.
    Zouboulis CC; Hansen H; Caposiena Caro RD; Damiani G; Delorme I; Pascual JC; Reguiai Z; Trigoni A; Vilarrasa E; Alfageme Roldán F
    Dermatology; 2020; 236(1):25-30. PubMed ID: 31630144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A centre-based ambulatory care concept for hidradenitis suppurativa improves disease activity, disease burden and patient satisfaction: results from the randomized controlled EsmAiL trial.
    Schultheis M; Staubach P; Nikolakis G; Schollenberger L; Mauch M; Burckhardt M; Heise M; Zamsheva M; Strobel A; Langer G; Bechara F; Kirschner U; Hennig K; Kunte C; Goebeler M; Grabbe S
    Br J Dermatol; 2023 Jul; 189(2):170-179. PubMed ID: 37132470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Results from Period A of RELIEVE, a Multicenter Randomized, Controlled Trial.
    Schultheis M; Staubach P; Nikolakis G; Grabbe S; Ruckes C; von Stebut E; Kirschner U; Matusiak Ł; Szepietowski JC
    Dermatology; 2022; 238(3):476-486. PubMed ID: 34535610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality-of-Life Impairment among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study of 1795 Patients.
    Krajewski PK; Matusiak Ł; von Stebut E; Schultheis M; Kirschner U; Nikolakis G; Szepietowski JC
    Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33429896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study.
    Rivera-Díaz R; Pozo T; Alfageme F; Díaz Ley B; Osorio GF; Chico R; Vilarrasa E; Silvente C; Ciudad Blanco C; Romaní J; Martorell A; Fernández P; Romero Ferreiro C; Molina Leyva A
    Actas Dermosifiliogr; 2023 Oct; 114(9):755-762. PubMed ID: 37331620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between Depression, Quality of Life and Clinical Severity in Patients with Hidradenitis Suppurativa.
    Sampogna F; Fania L; Mastroeni S; Fusari R; Napolitano M; Ciccone D; Mazzanti C; Pallotta S; Panebianco A; Abeni D
    Acta Derm Venereol; 2020 Nov; 100(18):adv00319. PubMed ID: 32985674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.